RXi Pharmaceuticals, Thera Neuropharma deal

Thera Neuropharma licensed exclusive rights to RXi’s sd-rxRNA platform to develop and commercialize therapeutics for neurodegenerative diseases. Thera Neuropharma plans to initially focus on developin...